Halo Therapeutics selected finalist in OBN Awards 2022
The OBN Awards, now in their 14th year, are a highly regarded and sought-after awards programme for the Life Sciences industry, designed to celebrate innovation and outstanding achievement across all corners of the life sciences industry.
Global health solutions: Anti-virals innovation post-COVID
As long as humans inhabit the earth, viruses will be part of life, and learning how to defend against novel coronaviruses will be vital for global health.
Oxford and Halo scientists reveal LA and sugar binding to SARS-CoV-2 spike at atomic resolution
The surface proteins found on
both pathogens and host cells mediate cell
entry (and exit) and influence disease progression and transmission. Both types of proteins can bear host-generated posttranslational
UK’s autumn Covid wave could be worse than the last as cases rise
There is a mixture of variants in circulation, and signs of vaccine fatigue in the population.
After two winters of Covid anguish, one would be forgiven for viewing the shortening of days with a sense of trepidation. It would not be entirely misplaced.
Rapidly escalating COVID-19 cases amid reduced virus surveillance forecasts a challenging autumn and winter in the WHO European Region
New WHO/Europe strategy urges countries to urgently address gaps in pandemic monitoring and response to avoid preventable deaths and severe disruptions to health systems
Halo co-founder and CSO Prof Imre Berger elected to the Fellowship of the Academy of Medical Sciences
Imre Berger, Professor of Biochemistry and Chemistry and Director of Bristol’s Max Planck Centre for Minimal Biology has been elected as a Fellow of the Academy of Medical Sciences for his outstanding contributions to biomedical science and notable discoveries during the COVID-19 pandemic.